Covid-19: New antibody drug to fight Omicron receives US FDA authorization

The US Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of Covid-19.The Biden administration purchased 600,000 doses before the authorization and will begin distribution of initial supplies to state health authorities 

from mint - Science https://ift.tt/xpekNVU
https://ift.tt/7vxO08M